Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10329320 Neuroactive steroids, compositions, and uses thereof

Patent 10329320 was granted and assigned to SAGE Therapeutics on June, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 11 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12083131 Neuroactive steroids, compositions, and uses thereof
0
Edits on 28 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12071453 Neuroactive steroids, compositions, and uses thereof
0
Edits on 14 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12060386 Compositions and methods for treating CNS disorders
0
Edits on 31 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 4 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11945836 Compositions and methods for treating CNS disorders
0
Edits on 9 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 9 Dec, 2023
Edits made to:
Article (+76 characters)
Article

Patent abstract

Described herein are neuroactive steroids of the Formula (I):

Edits on 22 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1032932000
Edits on 26 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Edits on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
Edits on 8 Feb, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 Feb, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11571432 Compositions that preferentially potentiate subtypes of GABA
0
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
SAGE Therapeutics
SAGE Therapeutics
0
Current Assignee
SAGE Therapeutics
SAGE Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
103293200
Date of Patent
June 25, 2019
0
Patent Application Number
155522010
Date Filed
February 19, 2016
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=103293200
Patent Citations Received
‌
US Patent 10857163 Compositions that preferentially potentiate subtypes of GABA
0
‌
US Patent 10870677 Compositions and methods for treating CNS disorders
0
Patent Primary Examiner
‌
Valerie Rodriguez-Garcia
0
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10329320
Edits on 8 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10870677 Compositions and methods for treating CNS disorders
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10857163 Compositions that preferentially potentiate subtypes of GABA
Edits on 27 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 27 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10329320 Neuroactive steroids, compositions, and uses thereof

Infobox
Is a
Patent
Patent
Patent applicant
SAGE Therapeutics
SAGE Therapeutics
Current assignee
SAGE Therapeutics
SAGE Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10329320
Date of patent
June 25, 2019
Patent application number
15552201
Date Filed
February 19, 2016
Patent primary examiner
‌
Valerie Rodriguez-Garcia

Find more entities like US Patent 10329320 Neuroactive steroids, compositions, and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.